// App-Quantinova.ai

4714 : In vivo efficacy of BET inhibitor BAY 1238097 in preclinical models of melanoma and lung cancer

Researchers

Presenter

  • Olaf Klingbeil

Principal Investigators

  • Bernard Haendler

  • Antje Stresemann

  • Claudia Merz

  • Annette Walter

  • Amaury Ernesto Fernandez-Montalvan

  • Matthias Ocker

  • Stephan Siegel

  • Pascale Lejeune

Medical Centers

  • Bayer Pharma AG, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Lung Cancer

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved